CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (24,641,437)	$ (21,110,774)
Less: Net loss from discontinued operations	(1,697,744)	(717,426)
Net loss from continuing operations	(22,943,693)	(20,393,348)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation	357,083	2,392,937
Amortization	251,968	400,661
Amortization of right-of-use assets	46,830	10,563
Interest expense - debt discount	2,379,196	3,034,454
Fair value of warrants issued to extinguish debt	2,749,259
Fair value in excess of proceeds upon issuance of warrants		1,763,481
Change in fair value of warrant liability		(1,112,665)
Accretion of original issue discount on notes receivable - related party	20,532	(1,869,778)
Accretion of original issue discount on notes receivable	(4,538)	(77,155)
Increase in accrued interest on notes receivable - related party		(732,542)
Stock-based compensation	272,466	1,354,062
Impairment of property and equipment		4,315,856
Realized losses on other investments	27,500
Realized (gains) losses on sale of digital currencies		(394)
Realized (gains) losses on sale of marketable securities	(22,602)	(86,741)
Unrealized (gains) losses on marketable equity securities	132,106	(294,717)
Unrealized losses on equity securities - related party	(25,176)	371,970
Unrealized losses on equity securities	72,976	24,597
Changes in operating assets and liabilities:
Accounts receivable	(590,502)	(398,222)
Accounts receivable, related party		2,648,798
Accrued revenue	599,604	(41,760)
Digital currencies	(14)	(599,025)
Inventories	(198,930)	613,847
Prepaid expenses and other current assets	(750,069)	(33,812)
Other assets	(86,143)	(433,013)
Accounts payable and accrued expenses	11,988,091	1,155,024
Accounts payable, related parties	(26,035)	4,526
Other current liabilities	407,910	(354,773)
Lease liabilities	(13,047)	16,216
Net cash (used in) continuing operating activities	(5,355,228)	(8,320,953)
Net cash provided by (used in) discontinued operating activities	1,246	62,205
Net cash used in operating activities	(5,353,982)	(8,258,748)
Cash flows from investing activities:
Purchase of property and equipment	(554,462)	(137,263)
Investments - related party	(516,634)	(1,501,912)
Investments in warrants and common stock - related party	(93,222)	(1,102,619)
Sales of marketable equity securities	143,667	571,741
Proceeds from loans receivable	139,933
Investments in debt and equity securities	(13,260)	(504,393)
Net cash used in investing activities	(893,978)	(2,674,446)
Cash flows from financing activities:
Gross proceeds from sales of common stock and warrants		15,945,371
Proceeds from issuance of Series A Convertible Preferred Stock		131,741
Financing cost in connection with sales of equity securities	(25,000)	(1,401,764)
Proceeds from warrant exercises		127,000
Proceeds from convertible notes payable	100,000	500,000
Proceeds from notes payable	7,122,434	4,752,918
Proceeds from short-term advances	570,000
Payments on short-term advances	(30,000)
Proceeds from short-term advances - related party	653,124	625,500
Payments on short-term advances - related party	(230,366)
Payments on notes payable	(289,012)	(2,001,474)
Payments on convertible notes payable		(7,079,547)
Proceeds from advances on future receipts		941,804
Payments on advances on future receipts	(762,076)	(1,365,435)
Payments of preferred dividends	(10,327)	(12,437)
Payments on revolving credit facilities, net	(44,363)	(80,445)
Net cash provided by financing activities	7,054,414	11,083,232
Effect of exchange rate changes on cash and cash equivalents	(15,429)	(165,125)
Net increase in cash and cash equivalents	791,025	(15,087)
Cash and cash equivalents at beginning of period	483,383	769,619
Cash and cash equivalents at end of period	1,274,408	754,532
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	100,939	1,850,946
Non-cash investing and financing activities:
Cancellation of convertible note payable into shares of common stock	16,710,803	4,736,295
Payment of accounts payable with digital currency		594,320
Issuance of common stock in payment of liability	228,701	108,521
Cancellation of short term advances, related party into shares of common stock	739,948
Conversion of loans receivable for marketable equity securities		485,000
Conversion of loans receivable for investments in warrants and common stock - related party		91,483
Issuance of notes payable and convertible notes payable in payment of accrued expenses	$ 420,000